Lung Cancer Research Foundation Announces Research Collaboration with Israel Cancer Research Fund
The Lung Cancer Research Foundation (LCRF) is pleased to announce its partnership with Israel Cancer Research Fund (ICRF) on ...
GoodNewsNetwork1d
Previously Failed Cancer Drug Repurposed to Act as ‘Flag’ for Cancer-Seeking Nuclear Missile
A discovery of how to target mutated proteins in tumors made a decade ago never matured into a surefire way of destroying ...
Scientists Just Made Cancer Radiation Therapy Smarter, Safer, and More Precise
Scientists at UC San Francisco have developed a revolutionary cancer treatment that precisely targets tumors with radiation ...
Cure Today7d
Explaining KRAS Mutations For Patients With Colorectal Cancer
Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.
EurekAlert!1d
New study suggests panitumumab with low-dose capecitabine as a safer, effective maintenance treatment for advanced colorectal cancer
A new research paper was published in Oncotarget, Volume 16, on February 12, 2025, titled “Could Panitumumab with very low ...
Cure Today12d
Lumakras Combo May Replace SOC in Third-Line Treatment for mCRC
Dr. Marwan G. Fakih discussed the FDA approval of Lumakras with Vectibix for third-line treatment of KRAS G12C-mutated ...
FierceBiotech13d
'Tough but necessary decisions': Frontier Medicines lays off staff to streamline operations
Precision medicines biotech Frontier Medicines is leaving behind an unknown number of staffers as it refocuses resources to ...
Targeted Oncology12d
FDA Grants Key Oncology Approvals and Designations in January 2025
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
Hosted on MSN21d
Silexion reports breakthrough in KRAS cancer therapy
The drug is designed to inhibit several oncogenic KRAS mutations, which are prevalent in various human cancers. Mitchell Shirvan, Ph.D., Chief Scientific Officer of Silexion, expressed enthusiasm ...